Many physicians empirically hold angiotensin-converting enzyme inhibitors before the administration of iodinated contrast. This prospective, single-center study, objectively quantifies the increased risk to contrast-induced nephropathy that patients would experience if they are exposed to angiotensin-converting enzyme inhibitors within 72 hours of exposure.

**************************************
Time Required (estimated): 20 minutes
Title: Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors of AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus-Diuresis (DVD) Trial
Citation: Nephrology Dialysis Transplantation 2010, Volume 25, pp. 759-64
Date Created: 2010
Revisions: None Indicated
Disclaimers: None Indicated
Resource Type: Text
Other: Recommended by Hitarth Dave, MS IV
Recommend to a Colleague/Friend
**************************************

Was this teaching resource valuable? Scroll down and complete our 6-point Transparent Peer Evaluation.



Transparent Peer Review
Your reviews are anonymous

GD Star Rating
loading...

To learn more about our 6-point transparent peer review system, click here



Share

Comments

  • Nephrology On-Demand Plus


    Our full-featured iOS app for the iPhone and iPad. NOD + integrates
    1. kidney education,
    2. training, and
    3. recruitment

    into a streamlined and user-friendly interface.


    Available_on_the_App_Store_(black)

  • Kidney Konnection


    A newsletter that discusses sophisticated topics in Nephrology for physicians in Internal Medicine.
    Click here to access your complimentary subscription
Read previous post:
Does Intensive Blood Pressure Control decrease cardiovascular events in Type II Diabetics?

This randomized controlled trial addresses the question of whether aggressive blood pressure control (systolic blood pressures lower than 120 mm...

Close